The Development of SARS-CoV-2 Variants: The Gene Makes the Disease
A novel coronavirus (SARS-CoV-2) emerged towards the end of 2019 that caused a severe respiratory disease in humans called COVID-19. It led to a pandemic with a high rate of morbidity and mortality that is ongoing and threatening humankind. Most of the mutations occurring in SARS-CoV-2 are synonymou...
Main Author: | Raquel Perez-Gomez |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-12-01
|
Series: | Journal of Developmental Biology |
Subjects: | |
Online Access: | https://www.mdpi.com/2221-3759/9/4/58 |
Similar Items
-
Characterization of a Broadly Neutralizing Monoclonal Antibody against SARS-CoV-2 Variants
by: Tasnim Saifudin Zakir, et al.
Published: (2022-01-01) -
Structure-function relations of the SARS-CoV-2 spike protein and impact of mutations in the variants of concern
by: Rey, Félix
Published: (2021-06-01) -
Uncovering a conserved vulnerability site in SARS‐CoV‐2 by a human antibody
by: Tingting Li, et al.
Published: (2021-11-01) -
Use of Lateral Flow Immunoassay to Characterize SARS-CoV-2 RBD-Specific Antibodies and Their Ability to React with the UK, SA and BR P.1 Variant RBDs
by: Enqing Tan, et al.
Published: (2021-06-01) -
Anti-SARS-CoV-2 Omicron Antibodies Isolated from a SARS-CoV-2 Delta Semi-Immune Phage Display Library
by: Ivette Mendoza-Salazar, et al.
Published: (2022-02-01)